AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Metastatic Breast Cancer
Interventions: DRUG: AZD2014|DRUG: Fulvestrant
Sponsor: AstraZeneca